Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2022
Blade Air Mobility reported a 187% increase in revenue to $26.6 million for Q1 2022, driven by growth in MediMobility Organ Transport and Jet revenues. The company added 14 new organ transportation clients and achieved a record passenger run-rate of 25,000 per week at Blade Airport. However, net loss rose to $11 million, attributed to increased general and administrative costs. Despite margin compression, Blade anticipates recovery and improved utilization as travel demand rebounds post-COVID.
- Revenue grew 187% YoY to $26.6 million.
- MediMobility revenues increased by 186% to $22.1 million.
- Added 14 new organ transportation clients.
- Achieved a record annualized weekly passenger run-rate of 25,000.
- Net loss increased to $11 million from $4.2 million YoY.
- General & Administrative costs rose by $9.2 million.
- Flight margin decreased to 11%, down from 16% YoY.
-
First quarter ended
March 31, 2022 revenue up187% to versus the prior year period$26.6 million
-
Added 14 new organ transportation clients in the period, contributing to
186% growth inMediMobility Organ Transport and Jet revenues versus the prior year period
-
Blade Airport recently saw record volumes with a 25,000 passenger annualized weekly run-rate this month, well above the pre-Covid andDecember 2021 peak
-
Blade
Europe established with the hiring of two rotorcraft industry veterans, to be headquartered inParis
“It's very rewarding to see such strong growth, both sequentially and year-over-year, in what has seasonally been the lightest quarter for Blade,” said
“Despite expected margin compression in the March quarter, we have seen a strong rebound in demand for our consumer-facing products in recent weeks as Covid restrictions have been lifted and Americans return to travel,” said
“Our distinctive asset-light approach has served us well,” said
First Quarter Ended
-
Total revenues increased
187% to in the current quarter versus$26.6 million in the prior year period$9.3 million
-
Short Distance revenues increased
300% to in the current quarter versus$4.2 million in the prior year period. Organic growth was driven by the resumption of our$1.1 million Blade Airport service and growth in demand for corporate and personal helicopter charter. Our acquisition ofHelijet's commuter passenger routes, which comprises ourVancouver business, contributed of revenues in the period, with depressed passenger volumes due to impacts from COVID-19 restrictions in$1.8 million British Columbia
-
MediMobility Organ Transport and Jet revenues increased186% to in the current quarter versus$22.1 million in the prior year period driven by the addition of new hospital and jet clients, our acquisition of Trinity Air Medical ("Trinity") and stronger demand for our seasonal BladeOne jet service between$7.7 million New York andSouth Florida
-
As expected, flight margin decreased this quarter, falling to
11% versus16% in the prior year period, driven primarily byBlade Airport service, which requires operating at low passenger utilization per flight during the ramp phase and Omicron impacts to bothBlade Airport andVancouver
-
Absent Blade Airport andVancouver , flight margin would have been approximately17% in the current quarter
-
We expect utilization in our
Blade Airport andVancouver businesses to improve from first quarter levels as a result of improving travel demand and the elimination of COVID-19 restrictions, while recent seat price increases across our business are expected to further improveFlight Margin in future quarters
-
Net loss increased to
in the current quarter versus net loss of$11.0 million in the prior year period, driven primarily by a$4.2 million increase in General & Administrative ("G&A") costs partially offset by a$9.2 million favorable change in the fair value of warrant liabilities$2.6 million
-
The increase in G&A is attributable to (i) a
increase in staff costs attributable to new hires to support the Company becoming public in$2.7 million May 2021 as well as our significant growth, both organically and through the consolidation of Trinity; (ii) a increase in legal and regulatory advocacy fees, which we do not expect to reoccur at this level; (iii) a$1.7 million increase in Directors & Officers (“D&O”) insurance expense following the Company becoming public; (iv) a$1.6 million increase in non-cash intangibles amortization costs in connection with the Trinity and$1.0 million Helijet transactions; and (v) a increase in mergers and acquisitions (“M&A”) transaction costs$1.0 million
-
Adjusted EBITDA decreased to
in the current quarter from$(7.7) million in the prior year period. The decrease versus the prior year period is primarily attributable to additional corporate and recurring expenses related to Blade’s growth and status as a public company, partially offset by increased$(2.2) million Flight Profit
-
Excluding
in new recurring public company expenses paid to third parties, primarily D&O insurance costs and professional fees, Comparable Adjusted EBITDA of$2.2 million in the current quarter decreased versus$(5.5) million in the prior year period, driven primarily by increased corporate expenses, partially offset by increased$(2.2) million Flight Profit
Business Highlights and Recent Updates
-
Blade's Airport business has continued to experience a rapid recovery from Omicron-related impacts, achieving a record annualized weekly passenger run-rate of approximately 25,000 fliers this month, well ahead of the pre-covid and
December 2021 peaks
-
On
April 20, 2022 Blade announced the formation of Blade Europe, which will be headquartered inParis, France , to accelerate international growth of Blade's urban air mobility network
-
On
April 14, 2022 Blade announced an expansion of its MediMobility footprint, with the addition of 14 new transplant centers in 2022, solidifying the company’s position as the largest dedicated air transporter of human organs for transplant inthe United States . Blade now serves more than 40 Organ Procurement Organizations and Transplant Centers in 20 US States
Conference Call
The Company will conduct a conference call starting at
Participants may access the call at 1-855-656-0926, international callers may use 1-412-317-5254, and request to join the Blade Urban Air Mobility earnings call. A live webcast will also be available by visiting the Investor Relations section of the Company’s website at https://ir.blade.com/news-events.
A telephonic replay will be available shortly after the conclusion of the call and until
Use of Non-GAAP Financial Information
Adjusted EBITDA - To supplement its consolidated financial statements, which are prepared and presented in accordance with
Comparable Adjusted EBITDA - To provide a like-for-like comparison of the current period (a “post going public” period) to “pre going public” periods, Blade reports Comparable Adjusted EBITDA, which is a non-GAAP financial measure. This measure excludes from the current period’s Adjusted EBITDA ongoing third-party costs driven by the Company becoming a public company, namely higher D&O insurance premiums and costs in connection with preparation of reviewed and audited periodical financial statements. Management believes Comparable Adjusted EBITDA provides meaningful supplemental information regarding our continuing operating performance by excluding from the current period the impact of these public company costs that did not affect prior periods. We expect to incur similar costs in future periods, and we do not anticipate presenting similarly adjusted measures once both the current period and the comparative prior period disclosed include these expenses.
Blade believes that these non-GAAP measures, viewed in addition to and not in lieu of our reported GAAP results, provide useful information to investors by providing a more focused measure of operating results, enhance the overall understanding of past financial performance and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making. The non-GAAP measures presented herein may not be comparable to similarly titled measures presented by other companies. Adjusted EBITDA, Comparable Adjusted EBITDA and
|
|||||||||||
|
For the Three Months Ended |
||||||||||
|
2022 |
|
2021 |
|
2020 |
||||||
Revenue |
$ |
26,630 |
|
|
$ |
9,273 |
|
|
$ |
6,454 |
|
|
|
|
|
|
|
||||||
Operating expenses |
|
|
|
|
|
||||||
Cost of revenue(1) |
|
23,707 |
|
|
|
7,797 |
|
|
|
5,872 |
|
Software development(1) |
|
835 |
|
|
|
289 |
|
|
|
319 |
|
General and administrative(1) |
|
13,978 |
|
|
|
4,825 |
|
|
|
2,856 |
|
Selling and marketing(1) |
|
1,800 |
|
|
|
587 |
|
|
|
755 |
|
Total operating expenses |
|
40,320 |
|
|
|
13,498 |
|
|
|
9,802 |
|
|
|
|
|
|
|
||||||
Loss from operations |
|
(13,690 |
) |
|
|
(4,225 |
) |
|
|
(3,348 |
) |
|
|
|
|
|
|
||||||
Other non-operating income (expense) |
|
|
|
|
|
||||||
Change in fair value of warrant liabilities |
|
2,550 |
|
|
|
— |
|
|
|
— |
|
Interest income (expense), net |
|
264 |
|
|
|
4 |
|
|
|
(61 |
) |
Realized loss from sale of short term investments |
|
(136 |
) |
|
|
— |
|
|
|
— |
|
Total other non-operating income (expense) |
|
2,678 |
|
|
|
4 |
|
|
|
(61 |
) |
|
|
|
|
|
|
||||||
Net loss |
$ |
(11,012 |
) |
|
$ |
(4,221 |
) |
|
$ |
(3,409 |
) |
__________
(1) Prior period amounts have been updated to conform to current period presentation.
|
||||||||
|
For the Three Months Ended |
|||||||
Product Line(1): |
2022 |
|
2021 |
|
2020 |
|||
Short Distance |
$ |
4,203 |
|
$ |
1,051 |
|
$ |
1,846 |
|
|
22,115 |
|
|
7,727 |
|
|
4,529 |
Other |
|
312 |
|
|
495 |
|
|
79 |
Total Revenue |
$ |
26,630 |
|
$ |
9,273 |
|
$ |
6,454 |
__________
(1) Prior period amounts have been updated to conform to current period presentation.
|
|||||||||||
|
For the Three Months Ended |
||||||||||
|
2022 |
|
2021 |
|
2020 |
||||||
Revenue |
$ |
26,630 |
|
|
$ |
9,273 |
|
|
$ |
6,454 |
|
Cost of revenue(1) |
|
23,707 |
|
|
|
7,797 |
|
|
|
5,872 |
|
|
$ |
2,923 |
|
|
$ |
1,476 |
|
|
$ |
582 |
|
|
|
11 |
% |
|
|
16 |
% |
|
|
9 |
% |
__________
(1) Cost of revenue consists principally of flight costs paid to operators of aircraft and landing fees. Prior period amounts have been updated to conform to current period presentation.
|
|||||||||||
|
For the Three Months Ended |
||||||||||
|
2022 |
|
2021 |
|
2020 |
||||||
Net Loss |
$ |
(11,012 |
) |
|
$ |
(4,221 |
) |
|
$ |
(3,409 |
) |
|
|
|
|
|
|
||||||
Stock-based compensation |
|
2,098 |
|
|
|
1,904 |
|
|
|
87 |
|
Depreciation and amortization |
|
1,145 |
|
|
|
126 |
|
|
|
131 |
|
Interest (income) expense, net |
|
(264 |
) |
|
|
(4 |
) |
|
|
61 |
|
Change in fair value of warrant liabilities |
|
(2,550 |
) |
|
|
— |
|
|
|
— |
|
Realized loss from sale of short term investments |
|
136 |
|
|
|
— |
|
|
|
— |
|
M&A transaction costs |
|
973 |
|
|
|
— |
|
|
|
— |
|
One-time legal and regulatory advocacy fees |
|
1,747 |
|
|
|
— |
|
|
|
— |
|
Adjusted EBITDA |
|
(7,727 |
) |
|
|
(2,195 |
) |
|
|
(3,130 |
) |
|
|
|
|
|
|
||||||
Post going public incremental |
|
1,608 |
|
|
|
— |
|
|
|
— |
|
Post going public professional services in connection with the preparation of periodical financial statements |
|
564 |
|
|
|
— |
|
|
|
— |
|
Post going public registration fees |
|
18 |
|
|
|
— |
|
|
|
— |
|
Comparable Adjusted EBITDA |
$ |
(5,537 |
) |
|
$ |
(2,195 |
) |
|
$ |
(3,130 |
) |
|
|
|
|
|
|
|
|||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
2,496 |
|
|
$ |
2,595 |
|
Restricted cash |
|
1,680 |
|
|
|
630 |
|
Accounts receivable |
|
6,019 |
|
|
|
5,548 |
|
Short-term investments (cost: |
|
266,560 |
|
|
|
279,374 |
|
Prepaid expenses and other current assets |
|
8,503 |
|
|
|
6,798 |
|
Total current assets |
|
285,258 |
|
|
|
294,945 |
|
|
|
|
|
||||
Non-current assets: |
|
|
|
||||
Property and equipment, net |
|
2,333 |
|
|
|
2,045 |
|
Investment in joint venture |
|
200 |
|
|
|
200 |
|
Intangible assets, net |
|
23,670 |
|
|
|
24,421 |
|
|
|
13,328 |
|
|
|
13,328 |
|
Operating right-of-use asset |
|
958 |
|
|
|
713 |
|
Other non-current assets |
|
880 |
|
|
|
232 |
|
Total assets |
$ |
326,627 |
|
|
$ |
335,884 |
|
|
|
|
|
||||
Liabilities and Stockholders' Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable and accrued expenses |
$ |
9,012 |
|
|
$ |
6,369 |
|
Deferred revenue |
|
6,281 |
|
|
|
5,976 |
|
Operating lease liability, current |
|
496 |
|
|
|
438 |
|
Total current liabilities |
|
15,789 |
|
|
|
12,783 |
|
|
|
|
|
||||
Non-current liabilities: |
|
|
|
||||
Warrant liability |
|
28,758 |
|
|
|
31,308 |
|
Operating lease liability, long-term |
|
466 |
|
|
|
278 |
|
Deferred tax liability |
|
144 |
|
|
|
144 |
|
Total liabilities |
|
45,157 |
|
|
|
44,513 |
|
|
|
|
|
||||
Commitments and Contingencies (Note 10) |
|
|
|
||||
|
|
|
|
||||
Stockholders' Equity |
|
|
|
||||
Preferred stock, |
|
— |
|
|
|
— |
|
Common stock, |
|
7 |
|
|
|
7 |
|
Additional paid-in capital |
|
370,794 |
|
|
|
368,680 |
|
Accumulated other comprehensive loss |
|
(1,901 |
) |
|
|
(898 |
) |
Accumulated deficit |
|
(87,430 |
) |
|
|
(76,418 |
) |
Total stockholders' equity |
|
281,470 |
|
|
|
291,371 |
|
|
|
|
|
||||
Total Liabilities and Stockholders' Equity |
$ |
326,627 |
|
|
$ |
335,884 |
|
|
|||||||||||
|
Three Months Ended |
||||||||||
|
2022 |
|
2021 |
|
2020 |
||||||
Cash Flows From Operating Activities: |
|
|
|
|
|
||||||
Net loss |
$ |
(11,012 |
) |
|
$ |
(4,221 |
) |
|
$ |
(3,409 |
) |
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities: |
|
|
|
|
|
||||||
Depreciation and amortization |
|
1,145 |
|
|
|
126 |
|
|
|
131 |
|
Stock-based compensation |
|
2,098 |
|
|
|
1,904 |
|
|
|
87 |
|
Change in fair value of warrant liabilities |
|
(2,550 |
) |
|
|
— |
|
|
|
— |
|
Realized loss from sale of short term investments |
|
136 |
|
|
|
|
|
||||
Unrealized foreign exchange gain / losses |
|
(5 |
) |
|
|
— |
|
|
|
— |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
||||||
Prepaid expenses and other current assets |
|
(1,705 |
) |
|
|
(828 |
) |
|
|
(192 |
) |
Accounts receivable |
|
(465 |
) |
|
|
473 |
|
|
|
(170 |
) |
Other non-current assets |
|
(648 |
) |
|
|
74 |
|
|
|
58 |
|
Operating lease assets/liabilities |
|
1 |
|
|
|
(2 |
) |
|
|
5 |
|
Accounts payable and accrued expenses |
|
2,636 |
|
|
|
1,872 |
|
|
|
(826 |
) |
Deferred revenue |
|
304 |
|
|
|
(3 |
) |
|
|
(458 |
) |
Net cash used in operating activities |
|
(10,065 |
) |
|
|
(605 |
) |
|
|
(4,774 |
) |
|
|
|
|
|
|
||||||
Cash Flows From Investing Activities: |
|
|
|
|
|
||||||
Purchase of property and equipment |
|
(437 |
) |
|
|
(53 |
) |
|
|
(10 |
) |
Purchase of short-term investments |
|
(265 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from sales of short-term investments |
|
11,699 |
|
|
|
— |
|
|
|
— |
|
Net cash provided by (used in) investing activities |
|
10,997 |
|
|
|
(53 |
) |
|
|
(10 |
) |
|
|
|
|
|
|
||||||
Cash Flows From Financing Activities: |
|
|
|
|
|
||||||
Proceeds from the exercise of stock options |
|
21 |
|
|
|
17 |
|
|
|
— |
|
Taxes paid related to net share settlement of equity awards |
|
(5 |
) |
|
|
— |
|
|
|
— |
|
Deferred recapitalization costs related to the merger |
|
— |
|
|
|
(1,770 |
) |
|
|
— |
|
Net cash provided by (used in) financing activities |
|
16 |
|
|
|
(1,753 |
) |
|
|
— |
|
|
|
|
|
|
|
||||||
Effect of foreign exchange rate changes on cash balances |
|
3 |
|
|
|
— |
|
|
|
— |
|
Net increase (decrease) in cash and cash equivalents and restricted cash |
|
951 |
|
|
|
(2,411 |
) |
|
|
(4,784 |
) |
Cash and cash equivalents and restricted cash - beginning |
|
3,225 |
|
|
|
10,337 |
|
|
|
17,368 |
|
Cash and cash equivalents and restricted cash - ending |
$ |
4,176 |
|
|
$ |
7,926 |
|
|
$ |
12,584 |
|
|
|
|
|
|
|
||||||
Reconciliation to the unaudited interim condensed consolidated balance sheets |
|
|
|
|
|
||||||
Cash and cash equivalents |
$ |
2,496 |
|
|
$ |
7,511 |
|
|
$ |
12,467 |
|
Restricted cash |
|
1,680 |
|
|
|
415 |
|
|
|
117 |
|
Total |
$ |
4,176 |
|
|
$ |
7,926 |
|
|
$ |
12,584 |
|
|
|
|
|
|
|
||||||
Non-cash investing and financing activities |
|
|
|
|
|
||||||
Adoption of new leases under ASC 842 entered into during the period |
$ |
415 |
|
|
$ |
12 |
|
|
$ |
— |
|
|
|||||
|
For the Three Months Ended |
||||
|
2022 |
|
2021 |
|
2020 |
Seats flown – all passenger flights(1) |
18,494 |
|
2,255 |
|
4,578 |
__________
(1) Prior period amounts have been updated to conform to current period presentation.
About
Blade is a technology-powered, global air mobility platform committed to reducing travel friction by providing cost-effective air transportation alternatives to some of the most congested ground routes in the
For more information, visit www.blade.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions and the negatives of those terms. These statements, which involve risks and uncertainties, relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to Blade’s future prospects, developments and business strategies. In particular, such forward-looking statements include statements concerning Blade’s estimated and future results of operations and shareholder returns, business strategies and plans, customer behavior, expenses, competitive position, industry environment and growth opportunities. These statements are based on management’s current expectations and beliefs, as well as a number of assumptions concerning future events. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.
Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Blade’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include: the duration and severity of the COVID-19 pandemic, failure of the markets for our offerings to grow as expected, or at all; our ability to attract and retain customers and increase existing customer utilization rates; the inability or unavailability to use or take advantage of the shift, or lack thereof, to EVA technology or the failure of such technology to deliver the expected results and cost savings; our ability to successfully enter new markets and launch new offerings; accidents or safety-related events involving small aircraft that create adverse publicity; the effects of competition; effects of pricing pressures; injuries to our reputation and brand; challenges to our ability to provide quality customer support at scale; events that cause decreases in our daily aircraft usage rates and flier utilization rates; shifts in customer preferences, discretionary spending and the ability of our customers to pay for our services; disruption of operations at the heliports and airports where our operations are concentrated; risks associated climate change, including potential increased impacts of severe weather and regulatory activity; the availability of aircraft fuel; technology system failures, defects, errors, or vulnerabilities and cyber-based attacks; our ability to receive favorable placements in mobile application marketplaces and effectively operate our mobile operating systems and applications; our ability to protect our intellectual property rights; risks related to our use of open source software; our ability to maintain and expand our facility and infrastructure network; our ability to obtain additional funding on acceptable terms, or at all; our ability to successfully navigate international expansion; our ability to identify, complete and successfully integrate acquisitions; our ability to manage future growth effectively; our ability or that of our third-party operators to obtain sufficient insurance at reasonable cost, or at all; the loss of key members of our management team; disruptions in the operations of our third-party operators, their failure to perform adequately, or their misuse of Blade-branded aircraft; the loss of our existing relationships with third-party operators or our inability to attract and retain qualified new operators to meet demand; disruptions or interference in our use of third-party web services; changes in our regulatory environment, including aviation law and
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005400/en/
For Media Relations
BladeMediaRelations@icrinc.com
Investor Relations
BladeIR@icrinc.com
Source:
FAQ
What are Blade Air Mobility's Q1 2022 revenue results?
How many new clients did Blade add in Q1 2022?
What was Blade's net loss for Q1 2022?
What is Blade's future outlook after the latest earnings report?